What is the Gufic Biosciences Ltd share price today?

The share price of NSE:GUFICBIO-EQ on 01 Oct 2026 (as of 15:03:41 IST) is ₹419.

What is the NSE:GUFICBIO-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:GUFICBIO-EQ 52 week high low range shows a high of ₹467.8 and a low of ₹268.

What is the Gufic Biosciences Ltd market cap?

As on 01 Oct 2026, Gufic Biosciences Ltd market cap is ₹43297000000.

What is the shareholding pattern of Gufic Biosciences Ltd Stock?

The shareholding pattern of Gufic Biosciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 72.5% Foreign Institutional Investors (FII): 0.47% Domestic Institutional Investors (DII): 0.24% Mutual Funds: 3.43% Retail & Others: 23.36% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Gufic Biosciences Ltd?

The Price-to-Earnings (PE) ratio of Gufic Biosciences Ltd is 58.9419, and the Price-to-Book (PB) ratio is 4.1406, as on 01 Oct 2026.

Gufic Biosciences Share Price

416.50+0.00 (-0.02%)

+26.92% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.02%

1 Week

+0.71%

1 Month

-0.76%

3 Month

+3.00%

6 Month

+37.71%

YTD

+23.96%

1 Year

+26.92%

5 Year

+115.25%

10 Year

+678.50%

Max

+1258.89%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

408.65

376.80

273.15

268.00

High

420.95

427.50

432.40

467.80

About

Gufic Biosciences Limited is a public company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

GUFICBIONSE

LTP

1W Low

1W High

Market cap (₹)

1769.9-7.8 (-0.44%)

1722

1855

4,24,202Cr

10064+284 (2.90%)

9621.50

10064

2,64,141Cr

4650+36.6 (0.79%)

4532

4675

1,74,402Cr

2323-82.5 (-3.43%)

2206.10

2441.90

1,26,811Cr

1240.6-4.9 (-0.39%)

1182

1254.20

1,23,685Cr

1368.3+16.3 (1.21%)

1336.70

1368.30

1,11,868Cr

1396.9+18 (1.31%)

1357

1396.90

1,11,650Cr

2475-17.8 (-0.71%)

2457.90

2528

1,02,196Cr

1694.5+13.1 (0.78%)

1647.20

1697.40

96,951Cr

2015.9+4.9 (0.24%)

1974

2033.80

91,301Cr

416.5+2.95 (0.71%)

407.70

427.50

4,171Cr

Gufic Biosciences Share Price

416.50+0.00 (-0.02%)

+26.92% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year15%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-8%

Stock Price CAGR

10 years23%

5 years17%

3 years15%

1 year27%

Return on Equity

10 years13%

5 years13%

3 years13%

Last year10%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	15%
-	-	-	-8%
23%	17%	15%	27%
13%	13%	13%	10%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

GUFICBIO

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
416.5	₹4171 Cr	56.78	2.23	10.4	₹64 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
₹261 Cr	₹252 Cr	₹231 Cr	₹237 Cr	₹224 Cr	₹205 Cr	₹208 Cr	₹204 Cr	₹203 Cr	₹195 Cr	₹202 Cr	₹215 Cr
₹46 L	-₹1 Cr	₹79 L	₹2 Cr	₹93 L	₹39 L	₹2 Cr	₹11 L	₹1 Cr	₹88 L	₹42 L	₹33 L
₹261 Cr	₹251 Cr	₹232 Cr	₹239 Cr	₹225 Cr	₹205 Cr	₹210 Cr	₹204 Cr	₹204 Cr	₹196 Cr	₹202 Cr	₹215 Cr
₹222 Cr	₹212 Cr	₹206 Cr	₹207 Cr	₹198 Cr	₹186 Cr	₹178 Cr	₹170 Cr	₹171 Cr	₹165 Cr	₹169 Cr	₹180 Cr
₹47 Cr	₹46 Cr	₹34 Cr	₹40 Cr	₹34 Cr	₹27 Cr	₹36 Cr	₹39 Cr	₹37 Cr	₹35 Cr	₹37 Cr	₹40 Cr
₹9 Cr	₹9 Cr	₹8 Cr	₹10 Cr	₹9 Cr	₹8 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹4 Cr
₹30 Cr	₹29 Cr	₹18 Cr	₹23 Cr	₹17 Cr	₹11 Cr	₹26 Cr	₹29 Cr	₹28 Cr	₹27 Cr	₹30 Cr	₹31 Cr
₹22 Cr	₹22 Cr	₹12 Cr	₹17 Cr	₹13 Cr	₹8 Cr	₹19 Cr	₹22 Cr	₹21 Cr	₹20 Cr	₹22 Cr	₹23 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024
—	—	—
₹10 Cr	₹10 Cr	₹10 Cr
₹0	₹10 L	₹0
₹655 Cr	₹591 Cr	₹523 Cr
₹655 Cr	₹591 Cr	₹523 Cr
₹665 Cr	₹601 Cr	₹533 Cr
₹4 L	₹0	₹0
₹105 Cr	₹131 Cr	₹154 Cr
₹17 Cr	₹8 Cr	₹2 Cr
₹20 Cr	₹25 Cr	₹17 Cr
₹18 Cr	₹17 Cr	₹15 Cr
₹160 Cr	₹181 Cr	₹188 Cr
—	—	—
₹199 Cr	₹159 Cr	₹166 Cr
₹58 Cr	₹70 Cr	₹56 Cr
₹254 Cr	₹154 Cr	₹142 Cr
₹6 Cr	₹4 Cr	₹7 Cr
₹518 Cr	₹388 Cr	₹372 Cr
₹1342 Cr	₹1169 Cr	₹1093 Cr
₹12 Cr	₹6 Cr	₹7 Cr
₹385 Cr	₹310 Cr	₹317 Cr
—	—	—
₹630 Cr	₹614 Cr	₹246 Cr
₹139 Cr	₹108 Cr	₹87 Cr
₹491 Cr	₹506 Cr	₹159 Cr
₹22 Cr	₹22 Cr	₹307 Cr
₹2 Cr	₹2 Cr	₹2 Cr
₹2 Cr	₹2 Cr	₹2 Cr
₹24 Cr	₹13 Cr	₹23 Cr
₹2 Cr	₹2 Cr	₹1 Cr
₹540 Cr	₹545 Cr	₹492 Cr
—	—	—
₹324 Cr	₹217 Cr	₹200 Cr
₹297 Cr	₹315 Cr	₹330 Cr
₹76 Cr	₹29 Cr	₹13 Cr
₹2 Cr	₹2 Cr	₹4 Cr
₹102 Cr	₹63 Cr	₹53 Cr
₹802 Cr	₹625 Cr	₹600 Cr
₹284 Cr	₹237 Cr	₹228 Cr
₹1342 Cr	₹1169 Cr	₹1093 Cr
₹66	₹60	₹53
₹66	₹60	₹53

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024
₹87 Cr	₹94 Cr	₹116 Cr
₹65 Cr	₹44 Cr	₹34 Cr
-₹95 Cr	₹7 Cr	-₹130 Cr
₹57 Cr	₹145 Cr	₹20 Cr
₹45 Cr	₹123 Cr	-₹7 Cr
-₹31 Cr	-₹71 Cr	-₹102 Cr
₹32 Cr	-₹37 Cr	₹82 Cr
₹46 Cr	₹15 Cr	-₹27 Cr
₹16 Cr	₹1 Cr	₹29 Cr
₹62 Cr	₹16 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Gufic Biosciences Share Price

416.50+0.00 (-0.02%)

+26.92% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 3 out of 9 oscillators

RSI

51.25Neutral

STOCH %K

73.65Neutral

MACD Level(12,26)

-1.21Sell

Ultimate Oscillator

55.72Buy

Aroon Oscillator

-58.00Sell

BOP

-0.14Sell

CCI

37.20Neutral

Williams %R

-26.35Neutral

Momentum

4.00Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 8

Bearish signals: 1 out of 9 moving averages

EMA 9

413.69Buy

SMA 9

411.42Buy

EMA 21

413.76Buy

SMA 21

411.35Buy

EMA 50

413.21Buy

SMA 50

420.57Sell

EMA 200

377.92Buy

SMA 200

353.73Buy

WMA 20

410.74Buy

Pivot

Classic

Resistance 5

488.03

Resistance 4

470.53

Resistance 3

453.03

Resistance 2

435.53

Resistance 1

426.07

Pivot

418.03

Support 1

408.57

Support 2

400.53

Support 3

383.03

Support 4

365.53

Support 5

348.03

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

408.65

376.80

273.15

268.00

259.75

171.75

37.00

2.55

High

420.95

427.50

432.40

467.80

504.25

Returns

+0.00

+2.95

-3.20

+12.15

+114.05

+80.50

+88.35

+145.90

+223.00

+363.00

+385.85

Beta

—

Std. deviation %

—

Open a free Demat account in minutes to start investing and screening .

Gufic Biosciences Share Price

416.50+0.00 (-0.02%)

+26.92% past 1 Year

Shareholding summary

Promoters

72.5%

FII

0.44%

DII

0.35%

3.03%

Others

23.68%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
72.50%	72.50%	72.50%	72.50%	72.50%	72.52%
0.44%	0.47%	0.42%	0.44%	0.33%	0.32%
0.35%	0.24%	0.20%	0.21%	0.18%	0.00%
3.03%	3.43%	3.63%	3.53%	3.48%	3.38%
23.68%	23.36%	23.25%	23.32%	23.51%	23.78%

Bulk & block deals

Name

Graviton Research Capital Llp

Financial Investors Trust A/C Grandeur Peak Global Opportunities Fund

Graviton Research Capital Llp

Gkn Securities

Parth Infin Brokers Pvt. Ltd.

Sbi Mutual Fund

Sambhav Properties Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Nov 2023	Sell	19.38 Cr	₹329.72	5.88 L	Bulk	0.586131	NSE
30 Nov 2023	Purchase	19.38 Cr	₹329.69	5.88 L	Bulk	0.586131	NSE
12 Aug 2021	Purchase	10.29 Cr	₹205.89	5 L	Bulk	0.498591	NSE
12 May 2021	Purchase	8.75 Cr	₹190.06	4.60 L	Bulk	0.458829	NSE
12 May 2021	Sell	8.74 Cr	₹189.94	4.60 L	Bulk	0.458829	NSE
18 May 2017	Sell	3.52 Cr	₹73.31	4.81 L	Bulk	0.479214	NSE
18 May 2017	Sell	10.07 Cr	₹73.72	13.66 L	Bulk	1.36246	BSE
18 May 2017	Purchase	10.11 Cr	₹72.67	13.91 L	Bulk	1.38739	BSE
18 May 2017	Purchase	3 Cr	₹60.10	5 L	Bulk	0.498591	BSE
18 May 2017	Sell	42.70 Cr	₹60.14	71 L	Bulk	7.079999	BSE

Insider trading & SAST

Client name

Jayesh Choksi

Jayesh P Choksi & Pacs

Jayesh Choksi

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
03 Jun 2022	Promoter & Director	Disposal	0.464181	25.49	9.79 Cr	₹217.65	4.50 L	02 Jun 2022	Market Sale	2,47,08,829	Insider Trading	—	Equity Shares
03 Jun 2022	Promoter	Disposal	0.48	25.47	0	—	4.68 L	02 Jun 2022	Market	2,46,90,829	SAST	29(2)	—
03 Jun 2022	Promoter & Director	Disposal	0.018567	25.47	39.68 L	₹220.43	18 K	02 Jun 2022	Market Sale	2,46,90,829	Insider Trading	—	Equity Shares

Gufic Biosciences Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Gufic Biosciences Share Price

Gufic Biosciences Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Gufic Biosciences Share Price

Gufic Biosciences Share Price

Oscillators

Moving averages

Gufic Biosciences Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Gufic Biosciences Share Price

Corporate Actions

Company details

Gufic Biosciences Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Gufic Biosciences Share Price

News

Gufic Biosciences Receives Three USFDA Observations At Pithampur Facility

Gufic Biosciences rules out greenfield capex, limits spend to replacement needs

Gufic Biosciences maintains gross debt near Rs 400 crores for growth needs

Gufic Biosciences shares guidance for EBITDA margin expansion through FY2030

Gufic Biosciences projects steady annual improvement in gross margin profile

Gufic Biosciences issues revenue growth guidance indicating stronger FY performance outlook

Gufic Biosciences surges on getting nod to make further investment in Saraswat Co-operative Bank

Gufic Biosciences posts strong Q4 EBITDA growth with improved margins YoY

Gufic Biosciences Q4 FY earnings show strong profit and revenue growth

Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank

Gufic Biosciences reports Profit after tax of 20.58 Crores, in the March 2026 quarter

Gufic Biosciences makes investment of $50,000 in Selvax

Gufic Biosciences invests USD 50,000 in Selvax Pty Ltd by acquiring 378,350 shares.

Gufic Biosciences reports Profit after tax of 15.56 Crores, in the December 2025 quarter

Gufic Biosciences Q3FY26 Earnings: Revenue Up 11%, EBITDA Growth 3.63%, PAT Down 19%.

Gufic BioSciences Q3FY26 Results: Revenue Up 11% YoY, Net Profit Down 19% YoY.

Gufic Biosciences targets strong export-led growth in injectables; Indore facility operational by FY26

Gufic Biosciences reports Profit after tax of 14.93 Crores, in the September 2025 quarter

Gufic Biosciences Q2 FY25 EBITDA declines YoY; EBITDA margin contracts on lower revenue.

Gufic Biosciences Q2 Net Profit and Revenue Update

Gufic Biosciences Ltd Share Price Today

Gufic Biosciences Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator